Quantitative determination of pravastatin and R-416, its main metabolite in human plasma, by liquid chromatography-tandem mass spectrometry
スポンサーリンク
概要
著者
-
KAWABATA Kiyoshi
Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co. Ltd.
-
SAMATA Naozumi
Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co. Ltd.
-
URASAKI Yoko
Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co. Ltd.
-
Urasaki Yoko
Drug Metabolism And Pharmacokinetics Research Laboratories Sankyo Co. Ltd.
-
Samata Naozumi
Drug Metabolism And Pharmacokinetics Research Laboratories Sankyo Co. Ltd.
-
Kawabata Kiyoshi
Drug Metabolism And Pharmacokinetics Research Laboratories Sankyo Co. Ltd.
関連論文
- Enantioselective determination of azelnidipine in human plasma using liquid chromatography-tandem mass spectrometry
- Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects
- Simultaneous determination of azelnidipine and two metabolites in human plasma using liquid chromatography-tandem mass spectrometry
- Quantitative determination of pravastatin and R-416, its main metabolite in human plasma, by liquid chromatography-tandem mass spectrometry